AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study Meeting Abstract


Authors: Dummer, R.; Robert, C.; Chapman, P. B.; Sosman, J. A.; Middleton, M.; Bastholt, L.; Kemsley, K.; Cantarini, M. V.; Morris, C.; Kirkwood, J. M.
Abstract Title: AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 491s
Language: English
ACCESSION: WOS:000208457403209
DOI: 10.1200/jco.2008.26.15_suppl.9033
PROVIDER: wos
Notes: Meeting Abstract: 9033 -- Source: Wos
Altmetric Score
MSK Authors
  1. Carol Morris
    53 Morris
  2. Paul Chapman
    246 Chapman